1. Alvord, E. C., Forno, L. S., Kusske, J. A.: A comparison of degeneration in cerebral cortex and brainstem. Adv. Neurol.5, 175–193 (1974).
2. Barbeau, A.: The clinical physiology of side-effects in long-term L-DOPA therapy. In: Advances in Neurology (McDowell, F. H., Barbeau, A., eds.), pp. 347–365. New York: Raven Press. 1974.
3. Barbeau, A.: Pathophysiology of the oscillations in performance after longterm therapy with L-Dopa. In: Advances in Parkinsonism (Birkmayer, W., Hornykiewicz, O., eds.), pp. 424–434. Basle: Editiones Roche. 1976.
4. Calne, D. B., Teychenne, P. F., Claveria, L. E., Eastman, R., Greenacre, J. K., Petrie, A.: Bromocriptine in parkinsonism. Br. Med. J.4, 442–444 (1974).
5. Calne, D. B., Plotkin, C., Williams, A. C., Nutt, J. G., Neophytides, A., Teychenne, P. F.: Long-term treatment of parkinsonism with bromocriptine. LancetI, 735–738 (1978).